surpass tirzepatide New research from the SURPASS-EARLY trial found that improved glycemic control, body weight, and waist circumference over 104 weeks compared with intensified conventional care in adults with early type 2 diabetes Read now: The SURPASS-EARLY trial

This therefore increases the chances of misdiagnosis, delayed appropriate treatment, and poor clinical outcomes (De Sanctis et al

If you want to support your routine alongside treatment, the GLP-1 Daily Support supplement is designed for everyday nutritional support during GLP-1 use

In a patient with a history of hiatal hernia, is it safe to start a GLP-1 receptor agonist (glucagon-like peptide1 receptor agonist)?

Like any medication, Wegovy comes with important safety considerations, including possible side effects, serious risks, and certain conditions where it may not be safe to use

Israel witnesses a 94 percent drop in symptomatic Covid cases with Pfizers jab Israels largest healthcare provider has reported a 94 percent drop in symptomatic Covid-19 infections among 600,000 people who received two doses of the Pfizer-BioNTech vaccine